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Dietary saturated fat is linked to numerous chronic
diseases, including cardiovascular disease. Here we
study the role of the lipoprotein lipase inhibitorAngptl4
in the response to dietary saturated fat. Strikingly, in
mice lacking Angptl4, saturated fat induces a severe
and lethal phenotype characterized by fibrinopurulent
peritonitis, ascites, intestinal fibrosis, and cachexia.
These abnormalities are preceded by amassive acute
phase response induced by saturated but not unsatu-
rated fat or medium-chain fat, originating in mesen-
teric lymph nodes (MLNs). MLNs undergo dramatic
expansion and contain numerous lipid-laden macro-
phages. In peritoneal macrophages incubated with
chyle, Angptl4 dramatically reduced foam cell
formation, inflammatory gene expression, and chyle-
induced activation of ER stress. Induction of macro-
phage Angptl4 by fatty acids is part of a mechanism
that serves to reduce postprandial lipid uptake from
chyle into MLN-resident macrophages by inhibiting
triglyceride hydrolysis, thereby preventing macro-
phage activation and foam cell formation and protect-
ing against progressive, uncontrolled saturated fat-
induced inflammation.
INTRODUCTION
Studies indicate that elevated saturated fat consumption is
associated with increased risk for chronic diseases, including
cardiovascular disease and type 2 diabetes. However, the
underlying mechanisms and why specifically saturated fat is
harmful largely remain unknown. Consequently, there is a need580 Cell Metabolism 12, 580–592, December 1, 2010 ª2010 Elsevierto better understand the molecular mechanisms that govern
the response to dietary (saturated) fat ingestion.
After digestion of dietary fat, absorbed long-chain fatty acids
are incorporated into chylomicrons as triglycerides (TG) and
released into the circulation after passage through the intestinal
lymphatics. Hydrolysis of chylomicron-TG is catalyzed by the
enzyme lipoprotein lipase (LPL), which is anchored to the capil-
lary endothelium via heparin-sulfate proteoglycans and is a key
determinant of cellular fatty acid uptake (Merkel et al., 2002).
LPL is expressed at high levels in tissues that depend on fatty
acids as fuel (heart, skeletal muscle) or synthesize fats for
storage or secretion (adipose tissue, mammary tissue), but
high expression is also found in macrophages (Ostlund-Lindqv-
ist et al., 1983; Wang and Eckel, 2009).
Activity of LPL is governed via numerous mechanisms that act
primarily at the posttranscriptional and posttranslational level.
One important modulator of LPL activity is Angiopoietin-like
protein 4 (Angptl4) (Yoshida et al., 2002). Angptl4 was discov-
ered as a transcriptional target of the peroxisome proliferator-
activated receptor a and g and is expressed in numerous cell
types including adipocytes, hepatocytes, (cardio)myocytes,
and endothelial cells (Kersten et al., 2000; Yoon et al., 2000).
Studies using different transgenic mouse models of Angptl4
overexpression or deletion show that Angptl4 potently raises
plasma TG levels by suppressing LPL-mediated clearance of
plasma TG-rich lipoproteins (Koster et al., 2005; Mandard
et al., 2006; Xu et al., 2005).
Recently it was shown that deletion of other members of the
Angiopoietin-like protein family influences the development of
obesity-related complications in the C57Bl/6 mouse high-fat-
induced obesity model. Specifically, surviving Angptl6/ mice
developedmarked obesity, ectopic fat storage, and insulin resis-
tance. In contrast, mice overexpressing Angptl6 were leaner and
had improved insulin sensitivity (Oike et al., 2005). Deletion of
Angptl2 ameliorated adipose tissue inflammation and insulin
resistance in obese mice, whereas Angptl2 overexpressionInc.
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resistance (Tabata et al., 2009). Given the role of Angptl4 in
plasma clearance of dietary TG, we set out to study the effect
of Angptl4 deletion in the context of chronically elevated dietary
fat intake.
RESULTS
Angptl4–/– Mice Fed HFD Develop Fibrinopurulent
Peritonitis and Ascites
To examine the effect of Angptl4 on diet-induced obesity and its
metabolic consequences, wild-type (WT) and Angptl4/ mice
were fed a high-fat diet (HFD) containing saturated fat-rich palm
oil and compared with mice fed a low-fat diet (LFD) (see Table S1
available online). As expected based on its ability to inhibit LPL,
Angptl4/ mice had decreased plasma TG (Figure 1A) and
showed faster initial weight gain (Figure 1B) (Voshol et al., 2009).
Remarkably, bodyweights of Angptl4/ mice fed HFD reached
a plateau after around 12 weeks and declined thereafter (Fig-
ure 1B). The decrease in bodyweight was related to anorexia
noticeable after about 10weeks ofHFD (Figure 1C). AllAngptl4/
mice fed HFD ultimately die anywhere between 15 and 25 weeks.
The cause of death was identified by an animal pathologist as
severe fibrinopurulent peritonitis connected with ascites.
Large amounts of fibrin exudate covered the abdominal
organs in Angptl4/ mice fed a HFD (Figure 1D). Other macro-
scopic abnormalities included intestinal fibrosis (Figure 1E),
a compressed liver (Figure S1A), and a hyperplastic spleen
(data not shown). No such abnormalities were observed in
Angptl4/ mice fed LFD, even at high age (>1.5 years). Routine
clinical tests were performed on the ascites fluid, which varied in
color from purulent white to purulent red (Figure 1D, inset).
Ascites white blood cell count was extremely high in all animals
(25.5–34.1*109/L, diagnostic threshold <0.5*109/L), as was the
endotoxin concentration (50–120 EU/mL, zero threshold),
strongly suggesting bacterial peritonitis. Ascites fluid of some
animals tested positive for E. coli. The high protein concentration
(3.43–4.28 g/dL, diagnostic threshold >2.5 g/dL) and low serum-
ascites albumin gradient (SAAG, 0.11–0.34 g/dL, diagnostic
threshold <1.1 g/dL) indicated exudative ascites, thereby
excluding portal hypertension. The ascites TG concentration
was highly variable but clearly elevated (4.8–75.5mM, diagnostic
threshold 1.25 mM). Analysis of chylous ascites fluid by lipo-
protein profiling indicated an abundance of TG-rich lipoproteins
representing chylomicrons, as shown by immunostaining for
apoB (Figure 1F), suggesting leakage of chyle from lymphatic
vessels. Additionally, significant vascular leakage occurred, as
shown by the much lower protein concentration in chyle
(1.38–1.83 g/dL) compared to ascites fluid (3.43–4.28 g/dL).
Plasma endotoxin levels were significantly elevated in
Angptl4/ mice fed HFD for 19 weeks (Figure 1G). Microscopic
examination indicated that the fibrin exudate contained an abun-
dance of foam cells, polynuclear giant cells, and other leukocytes
(data not shown). The same cells as well as focal lymphocyte infil-
trates were observed in the small intestine (Figure 2A, inset) and
mesenteric fat (Figure 2B), in the former encapsulated by collagen
(Figure 2C). Intestinal lymph vessels were dilated, suggesting
mesenteric lymphatic obstruction (Figure 1H). Epididymal adipose
tissue had a red appearance (Figure S1C) and exhibited coagula-Cell Mtion necrosis and steatitis as shown by presence of lymphocytes,
granulocytes, and other leukocytes (Figure S1D, inset).
Livers of Angptl4/ mice fed HFD for 19 weeks were not
fibrotic but resembled an ischemic liver. Portal triads, cords,
and sinusoids were poorly visible, and clumping of nuclei was
seen, indicating collapse of liver (Figures S1A and S1B). Focal
infiltrates of neutrophils, eosinophils, and macrophages were
observed (Figure S1B, inset), as were rod-shaped bacteria. Liver
fat was almost absent, whereas it was elevated in Angptl4/
mice on LFD (Figure S1E). Weights of liver and epididymal fat
pads were significantly lower in Angptl4/ mice after 19 weeks
of HFD (Figures S1F and S1G), while epididymal fat pads were
heavier in Angptl4/ mice on the LFD. Taken together,
Angptl4/ mice chronically fed HFD develop a severe pheno-
type characterized by anorexia, cachexia, intestinal inflamma-
tion and fibrosis, chylous ascites, and fibrinopurulent peritonitis,
leading to the death of the animal.
Ascites and Other Clinical Abnormalities Are
Not Related to a Primary Lymph Vessel Defect
Angptl4/ mice on a mixed genetic background were reported
to die shortly after birth due to defective separation of intestinal
lymphatic and blood microvasculature (Backhed et al., 2007).
Although we did not find these abnormalities in Angptl4/
mice on pure C57Bl/6 background and adult Angptl4/ mice
in proper Mendelian ratios were obtained, one might suspect
an underlying primary weakness in intestinal lymphatics that
becomes manifest when chyle flow is increased, as observed
upon high-fat feeding, causing leakage of chyle into intestinal
lumen and peritoneal cavity. However, none of the clinical abnor-
malities including chylous ascites were observed in Angptl4/
mice fed a safflower oil-based HFD rich in polyunsaturated fat
(Table S2) (data not shown). Furthermore, if lymphatic vessels
are intrinsically more permeable, ascites and diarrhea, the latter
due to loss of protein and fat from lymph into the intestinal lumen,
should develop upon starting the HFD, which was not observed.
Surprisingly, fecal fat excretion was markedly decreased in
Angptl4/ mice, indicating more efficient fat absorption (Fig-
ure S2A). An acute intestinal lipid absorption test using 3H-triolein
and 14C-palmitic acid failed to show any differences in rate of
appearance of either label in blood between WT and Angptl4/
mice (Figures S2B and S2C), suggesting chylomicron formation
and release is similar between WT and Angptl4/ mice. In
contrast, in all intestinal parts, accumulation of both labels 5 hr
after lipid load was markedly higher in Angptl4/ mice (Figures
S2D and S2E). The similarity in results between 3H-triolein and
14C-palmitic acid argue against an effect of Angptl4 inactivation
on TG digestion but suggest enhanced fatty acid uptake into en-
terocytes. This is supported by elevated expression of target
genes of PPARa in small intestine ofAngptl4/mice, suggesting
enhanced gene regulation by fatty acids (Figures S2F and S2G).
Overall, the data argue against a primary lymph vessel defect
forming the basis for the severe pathology.
A Massive Acute Phase Response Precedes Ascites
in Angptl4–/– Mice Fed HFD
To investigate the cause of the severe pathology, WT and
Angptl4/ mice were studied before onset of anorexia and
cachexia at 8 weeks of HFD (Figures 1A and 1B), and beforeetabolism 12, 580–592, December 1, 2010 ª2010 Elsevier Inc. 581
Figure 1. Angptl4–/– Mice Chronically Fed HFD Develop Fibrinopurulent Peritonitis and Ascites
(A) Four hour fasting plasma TG levels during the course of chronic LFD or HFD intervention (study 1). Differences between LFD and HFD within each genotype
were not statistically significant. n = 10 per group.
(B) Bodyweight changes in WT and Angptl4/ mice fed LFD or HFD for 19 weeks.
(C) Mean daily food intake in WT and Angptl4/ mice fed LFD or HFD for 19 weeks.
(D)Whole-animal photographs taken immediately following sacrifice of representativeWT andAngptl4/mice fed either LFD or HFD for 19weeks. Pictures at far
right were taken after removal of peritoneum. Ascites fluid collected from two Angptl4/ mice fed HFD is shown at the bottom.
(E) Photograph of small intestine of WT and Angptl4/ mice fed LFD or HFD for 19 weeks.
(F) FLPC lipoprotein profiling of ascites fluid of Angptl4/ mice fed HFD for 19 weeks (n = 5). (Inset) apoB immunoblot of FPLC fractions from ascites fluid of
Angptl4/ mice or mouse fasting plasma (FP).
(G) Plasma endotoxin levels in WT and Angptl4/ mice fed LFD or HFD for 19 weeks.
(H) Lymph vessel area in jejunum of WT and Angptl4/mice fed LFD or HFD for 19 weeks determined after Lyve-1 staining. Error bars represent SEM. Asterisk
indicates significantly different from corresponding WT mice according to Student’s t test (p < 0.05).
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Figure 2. Severe Intestinal Inflammation in Angptl4–/– Mice Chroni-
cally Fed HFD
Representative H&E staining of small intestine (A) or mesenteric fat (B) of WT
and Angptl4/ mice fed HFD for 19 weeks (study 1). (Inset) High-magnifica-
tion image of lymphocyte infiltrate (top) or presence of granulocytes (bottom).
(C) Sirius red staining of small intestine of WT and Angptl4/mice fed HFD for
19 weeks. Arrow indicates inflammatory infiltrate.
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Strikingly, after 8 weeks of HFD, plasma levels of serum amyloid
A (SAA) and other inflammatory markers were dramatically
increased in Angptl4/ mice (Figures 3A and 3B). Whereas
IL-6 was undetectable in plasma of WT mice, levels averaged
63 ± 26 pg/mL in Angptl4/ mice (normal values <15 pg/mL).
These changes were paralleled by massive induction of hepatic
mRNA for SAA2 and other acute phase proteins haptoglobin and
lipocalin 2 (Figure 3C). Furthermore, increased expression of
macrophage/Kupffer cell marker Cd68 (Figure 3D) and
enhanced Cd68 immunostaining was observed (Figure 3E).
Consistent with these data, serum levels of negative acute phase
protein albumin were decreased (Figure 3F). Thus, Angptl4/
mice fed HFD exhibit systemic inflammation and a massive
acute phase response several weeks prior to development of
ascites and other clinical symptoms.
Chronic HFD is known to induce adipose tissue inflammation,
characterized by adipose infiltration of macrophages. However,
no signs of enhanced macrophage or other leukocyte infiltration
were observed in epididymal fat ofAngptl4/mice after 8weeks
of HFD (Figures S3A and S3B), suggesting that enhanced
systemic inflammation does not originate in the adipose tissue.
Inflammation in Angptl4–/– Mice Fed HFD Originates
in Mesenteric Lymph Nodes
Interestingly, a trend toward increased plasma SAA levels in
Angptl4/ mice was already visible after 1 week of HFD (Fig-Cell Mure 4A). HFD has been proposed to lead to inflammatory stress
via changes in intestinal microflora and/or increased release of
LPS (Cani et al., 2007). However, portal LPS levels were lowest
inAngptl4/mice fedHFD (Figure 4B). Importantly, the increase
in plasma SAA levels in Angptl4/mice by HFD was unaffected
by chronic oral antibiotic treatment (Figure 4C), which effectively
reduced intestinal bacterial counts (Figure 4D, Figure S4A) and
resulted in a severely enlarged caecum (data not shown). These
data suggest that induction of systemic inflammation in
Angptl4/ mice by HFD is independent of the intestinal
microbiota.
Remarkably, we noticed that the mesenteric lymph nodes
(MLNs) were dramatically enlarged in Angptl4/ mice already
after 5 weeks of HFD, indicating massive mesenteric lymphade-
nitis (Figures 4E and 4F). Inflammation extended to mesenteric
fat which exhibited mesenteric panniculitis (Figure S4B). High-
fat feeding is known to promote intestinal lymph flow and forma-
tion of chylomicrons, which pass through the MLN as chyle
before reaching the circulation. Hence, MLN are exposed to
extremely high TG concentrations, which reach 55 mM in rats
fed HFD (mean 35 ± 11 mM). To investigate the role of increased
chyle flow, mice were fed for 5 weeks a diet rich in medium chain
TGs (MCT) (Table S2), which are not processed via the lymph but
enter the portal vein as free fatty acids. Remarkably, induction of
plasma SAA and mesenteric lymphadenitis were absent in
Angptl4/ mice fed MCT (Figures 4G and 4H), suggesting the
response is mediated by chylomicrons. A safflower oil-based
HFD, which as mentioned previously did not provoke a clinical
phenotype, also did not promote inflammation in Angptl4/
mice, whereas a lard-based high saturated fat diet gave similar
results as the palm-oil based HFD (Figures 4G and 4H). Use of
a palm oil-based diet with intermediate fat content supported
a clear correlation between dietary saturated fat content and
plasma SAA in Angptl4/ mice (Figure 4I). Consistent with
a direct proinflammatory effect of saturated fat via chylomicrons,
there was a clear trend toward increased expression of several
inflammatory mediators in MLN of Angptl4/mice already after
1 day of HFD (Figure 4J, Figure S4C). These data indicate that in
Angptl4/ mice, a diet rich in saturated fat rapidly causes
severe mesenteric lymphadenitis and panniculitis via chylomi-
crons, leading to a massive hepatic acute phase response via
the connecting portal circulation.
Absence of Angptl4 Stimulates Foam Cell Formation
and Inflammation in MLN Macrophages
MLNs are packed with numerous immune cells including macro-
phages. Microscopic examination of MLN from Angptl4/mice
but not WT mice fed HFD for 5 weeks showed an abundance of
multinucleated Touton giant cells (Figures 5A and 5B), origi-
nating from fusion of aberrant lipid-laden tissue macrophages
as verified by F4/80 immunostaining (Figure 5C). Formation of
Touton cells is known to occur as reaction to lipid material in
lymph nodes and is characteristic of lipid lymphadenopathy
(Aterman et al., 1988). Accumulation of neutral lipids in Touton
cells was confirmed by oil red O (Figure 5D) and Sudan black
staining (Figure 5E). Importantly, Touton cells were spotted in
Angptl4/ mice already after 1 day of HFD (Figure S4D). The
data suggest a major role of MLN macrophages in initiating
inflammation in Angptl4/ mice fed HFD.etabolism 12, 580–592, December 1, 2010 ª2010 Elsevier Inc. 583
Figure 3. High-Fat Feeding Provokes
Massive Acute Phase Response in
Angptl4–/– Mice
(A) Plasma serum amyloid (SAA) levels in WT and
Angptl4/ mice fed LFD or HFD (study 1).
(B) Plasma levels of numerous cytokines inWT and
Angptl4/ fed HFD for 8 weeks. Values are ex-
pressed relative to WT.
(C) Hepatic mRNA levels of SAA2, haptoglobin,
and lipocalin 2 determined by qPCR. Expression
was normalized against 36B4.
(D) Hepatic mRNA levels of macrophage marker
Cd68.
(E) Cd68 immunostaining of liver sections of WT
and Angptl4/ mice fed HFD for 8 weeks.
(F) Plasma serum albumin levels. n = 4–11 mice
per group. Error bars represent SEM. Asterisk indi-
cates significantly different from corresponding
WT mice according to Student’s t test (p < 0.05).
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foam cell formation and provoke release of cytokines by mouse
peritoneal macrophages by serving as source of proinflamma-
tory saturated fatty acids (Gianturco et al., 1982; Saraswathi
and Hasty, 2006). This effect required LPL, which is highly ex-
pressed in macrophages (Babaev et al., 1999; Ostlund-Lindqvist
et al., 1983; Skarlatos et al., 1993) and lymph nodes (http://
biogps.gnf.org/) (Lattin et al., 2008). Microarray analysis indi-
cated that LPL was among the top 25 of genes with the highest
microarray expression signal in peritoneal mouse macrophages
(Table S3). Since Angptl4 is also expressed in macrophages, is
dramatically induced by chyle (Figure S5A), and can inhibit
macrophage LPL (Figure S5B), we hypothesized that Angptl4
minimizes lipolysis of chylomicrons by MLN macrophages and
accordingly suppresses uptake of proinflammatory saturated
fatty acids. To test this hypothesis, peritoneal macrophages
from Angptl4/ mice were incubated with chyle obtained from
themesenteric lymph duct of rats fed palm oil-based HFD. Chyle
dramatically increased lipid storage in macrophages leading to
foam cell formation, which was strongly reduced by the LPL
inhibitor orlistat (Figure S5C). Increased lipid uptake was verified
by elevated expression of PPAR-LXR target Abca1 and
decreased expression of SREBP targets, as shown by whole
genome expression profiling (Figure 6A) and qPCR (Figure S5D).
Importantly, increased lipid uptake was associated with584 Cell Metabolism 12, 580–592, December 1, 2010 ª2010 Elsevier Inc.pronounced induction of numerous
inflammation and immune-related genes,
as shown by significant overrepresenta-
tion of GO classes corresponding to
those pathways and by Ingenuity Canon-
ical Pathway analysis (Figures S6A and
S6B). Induction of inflammation, exempli-
fied byCxcl2,Gdf15, oncostatin M, Ptgs2
(COX-2), and other genes, was almost
entirely blunted by orlistat, indicating
lipolysis and LPLdependency (Figure 6A).
Some overlap in macrophage gene regu-
lation was observed between chyle and
LPS, but overall effects were mostly
divergent (Figure S6C). Specifically,typical targets of LPS such as IL-1b were not induced by chyle,
while numerous inflammatory genes upregulated by chyle were
not induced by LPS, including Gdf15 and Vegfa.
To examine whether Angptl4 canmimic the effect of orlistat on
macrophage inflammation,macrophageswere loadedwith chyle
in thepresenceof recombinantAngptl4. Angptl4 did not influence
cell viability, which was equally high in Angptl4- and PBS-treated
cells (>85%). At a concentration that causesmaximal inhibition of
LPL (Lichtenstein et al., 2007), Angptl4 prevented lipid uptake
from chyle (Figure 6B) and markedly reduced inflammation
(Figures 6A and 6C), as shown by strongly blunted induction of
inflammatory markers Ptgs2, Cxcl2, Ccr1, and Gdf15. Inhibitory
effects of Angptl4 andorlistat on chyle-elicited changes in inflam-
matory gene expression were highly similar and support
a commonmechanism of action (Figure 6A). No clear differences
in foam cell formation upon chyle loading were observed
between WT and Angptl4/ macrophages (Figure S5C), likely
because induction of Angptl4 protein by chyle in WT macro-
phages and subsequent feedback inhibition of lipid uptake via
LPL lag behind the extremely rapid rate of lipid uptake.
Angptl4 Abolishes Chyle-Induced ER Stress
in Macrophages
To explore the mechanismmediating the proinflammatory effect
of chyle, peritoneal macrophages were incubated with different
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signaling (Polymyxin B), sphingolipid biosynthesis (Myriocin),
and fatty acid translocase/Cd36 (Sulfosuccinimidyl oleate) (Fig-
ure 6D). None of the compounds showed any repressive effect
on chyle-induced inflammation, although the LPS inhibitor poly-
myxin B augmented expression of Gdf15 and Cxcl2.
Since ER stress was one of the canonical pathways signifi-
cantly altered by chyle (Table S6B) and is linked to activation of
inflammation (Hotamisligil, 2010), we further focused our investi-
gation on the ER stress pathway. The mammalian ER stress
pathway consists of three major branches: IRE1a, PERK, and
ATF6.UponER stress activation, IRE1a andPERKundergo auto-
phosphorylation and initiate downstream targets. IRE1a medi-
ates the splicing of XBP1 mRNA, while PERK phosphorylates
eIF2a, leading to attenuation of global translation and induction
of expression of Atf4 and Ddit3 (CHOP). Remarkably, similar to
the effect of ER stress inducers thapsigargin and tunicamycin,
chyle significantly increased total IRE1a protein and IRE1a phos-
phorylation (Figure 7A) anddramatically stimulatedXBP1splicing
(Figure 7B).Moreover, chyle stimulated phosphorylation of PERK
and its target eIF2a, markedly increased CHOP protein, and up-
regulated expression of many ER stress target genes including
XBP1s, CHOP, and Atf4 (Figure 7C). Importantly and consistent
with its antilipolytic role, effects of chyle on ER stress marker
genes were entirely abolished by Angptl4 (Figure 7D). Taken
together, chyle induces ER stress in macrophages, which may
account for the pronounced activation of inflammation.
Saturated and Unsaturated Fatty Acids Differentially
Modulate Angptl4 mRNA and ER Stress
Asmentionedabove, chyle dramatically increasedAngptl4mRNA
in WT peritoneal macrophages (Figure 7E). Similarly, individual
fattyacidsmarkedly increasedAngptl4mRNA inmouseperitoneal
and humanU937macrophages (Figure 7F). Compared to unsatu-
rated oleic and linoleic acid, the saturated palmitic acid was
significantly less potent in inducing Angptl4. In contrast, expres-
sion of IRE1a, XBP1s, CHOP, Atf4, and Gdf15 and to a lesser
extent Cxcl2 was specifically stimulated by palmitic acid (Fig-
ure 7G). Palmitic, oleic, and linoleic acid represent 95% of fatty
acids present in the various diets used, excluding the MCT diet.
Finally, to study which specific PPAR isotype is involved in
Angptl4 regulation by fatty acids, three types of macrophages
were treated with synthetic agonists for PPARa, PPARd, and
PPARg. No induction of Angptl4 expression was observed with
PPARa agonist Wy14643 (Figure S7A). The PPARd agonist
GW501516 consistently induced Angptl4 mRNA in all three cell
types,whereas thePPARgagonist rosiglitazone increasedAngptl4
mRNA in peritoneal macrophages and to a minor extent in U937
cells. These data suggest that PPARd most likely mediates the
effect of chylomicron-derived fatty acids on Angptl4 expression.
Taken together, these results demonstrate that Angptl4
protects MLN macrophages from uncontrolled lipid accumula-
tion after high-fat feeding, thereby preventing lipid-induced ER
stress and consequent inflammation.
DISCUSSION
After a saturated fat-rich meal, MLNs are exposed to extremely
high concentrations of chylomicrons via the chyle, which mightCell Mlead to generation of large amounts of proinflammatory satu-
rated fatty acids upon TG lipolysis. Our data indicate that
MLNs and specifically resident macrophages are protected
from the proinflammatory effect of saturated fatty acids via
expression of Angptl4, which is strongly induced by chyle and
fatty acids and which via inhibition of LPL prevents lipolysis of
chylomicron-TG. In the absence of this protective autocrine
mechanism, feeding a diet rich in saturated fat rapidly leads to
enhanced lipid uptake into MLN-resident macrophages, trig-
gering foam (Touton) cell formation and a massive inflammatory
response characterized by severe mesenteric lymphadenitis.
Concomitant induction of numerous cytokines leads to amassive
hepatic acute phase response via the connecting portal circula-
tion, further evolving into a progressive, uncontrolled inflamma-
tion that culminates in chylous ascites and fibrinopurulent
peritonitis. The data thus show that Angptl4 is a key player in
the protection against the severe proinflammatory effects of
dietary saturated fat. Based on our data in mice, it can be
hypothesized that human subjects homozygous for the E40K
mutation in Angptl4, which has reduced ability to inhibit LPL
and is associated with lower plasma TG (Romeo et al., 2007;
Shan et al., 2008; Yin et al., 2009), may be particularly sensitive
to the proinflammatory effects of dietary saturated fat.
According to microarray analysis, LPL was among the most
highly expressed genes in mouse peritoneal macrophages.
The ability of macrophage LPL to facilitate lipid uptake into
macrophages is well recognized (Babaev et al., 1999; Ostlund-
Lindqvist et al., 1983). The locally released fatty acids may serve
as energy source for active macrophages (Yin et al., 1997), but
may also constitute a potential proinflammatory stimulus.
Consistent with this notion, fatty acids offered to macrophages
as VLDL-TG are taken up and engage MAPK-mediated inflam-
matory pathways along with increased expression of several
proinflammatory cytokines (Saraswathi and Hasty, 2006). Our
data indicate that exposure of macrophages to elevated yet
physiologically relevant concentrations of chylomicrons
containing saturated fatty acids unleashes a vast inflammatory
response characterized by marked induction of numerous
chemokines and other inflammation-related genes, which is
entirely dependent on TG-lipolysis. We propose that expression
of Angptl4 in macrophages and its potent induction by chylomi-
cron-derived fatty acids are part of a feedback mechanism
aimed at protecting MLN-resident macrophages against post-
prandial lipid overload and associated inflammation.
Ablation of Angptl4 is associated with decreased plasma TG
levels caused by increased peripheral LPL activity (Koster
et al., 2005). Recent data indicate that endothelium-bound LPL
is stabilized by the protein GPIHBP1, which partially prevents
LPL inhibition by Angptl4 (Sonnenburg et al., 2009). Perhaps
the almost complete blockage of lipid uptake by Angptl4 in
macrophages as opposed to its more modest effect in muscle
and adipose tissue may be explained by the minimal expression
of GPIHBP1 in macrophages (Figure S7B) (Sonnenburg et al.,
2009). Future studies will have to address this issue in more
detail.
Feeding Angptl4/ mice a diet rich in polyunsaturated fatty
acids did not elicit an inflammatory response, consistent with
data in peritoneal macrophages showing lack of induction of
Gdf15 and Cxcl2 by oleic and linoleic acid. In contrast, oleicetabolism 12, 580–592, December 1, 2010 ª2010 Elsevier Inc. 585
Figure 4. Chyle Containing Saturated Fat Elicits Massive Mesenteric Lymphadenitis in Angptl4–/– Mice
(A) Kinetics of change in plasma SAA in WT and Angptl4/ mice fed HFD. n = 6–7 per group.
(B) Postprandial endotoxin levels in portal plasma from WT and Angptl4/ mice fed LFD or HFD for 5 weeks (study 2). n = 6–7 per group.
(C) Plasma SAA levels in WT and Angptl4/ mice fed HFD for 5 weeks being given oral antibiotics or vehicle (study 3). n = 6–10 per group.
(D) Relative abundance of total bacteria expressed per weight of colonic content in Angptl4/mice fed HFD and given oral antibiotics or vehicle. Asterisk indi-
cates significantly different from corresponding WT mice according to Student’s t test (p < 0.05).
(E) Photograph of mesenteric fat of Angptl4/ mouse fed HFD for 5 weeks (study 2). Position of dramatically enlarged lymph node is indicated.
(F) MLN of WT and Angptl4/ mice fed HFD for 5 weeks after dissection and removal of adipose tissue.
(G) Plasma SAA levels in WT and Angptl4/mice fed LFD or different types of HFD for 5 weeks (study 2). HF-MCT, high-fat medium-chain triglycerides; HF-lard,
high-fat lard-based; HF-palm, high-fat palm oil-based; HF-safflower, high-fat safflower oil-based.
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Figure 5. Touton Giant Cells Are Abundant
in MLN of Angptl4–/– Mice Fed HFD
(A) Low-magnification image of H&E staining of
MLN from WT and Angptl4/ mice fed HFD for
5 weeks (study 2). Touton giant cells are indicated
by yellow arrows. (B) High-magnification image of
MLN with Touton giant cells from Angptl4/mice
fed HFD for 5 weeks (C) F4/80 immunostaining of
MLN with Touton giant cell. (D) Oil red O staining
counterstained with hematoxylin. (E) Sudan black
staining.
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expression compared to palmitic acid, suggesting that the
Angptl4-mediated feedback inhibition of lipid uptake and inflam-
mation is disturbed in presence of saturated fatty acids.
An important question is how chyle induces inflammation in
macrophages. Use of chemical inhibitors indicated that the
response is not mediated by LPS, is not dependent on Cd36-
mediated fatty acid transport, and does not require sphingolipid
synthesis. Strikingly, chyle caused pronounced activation of
different branches of the ER stress pathway. It has been shown
that ER stress can promote inflammation by various mecha-
nisms, including via IRE1a-mediated activation of stress kinases
such as the c-Jun N-terminal kinase (Urano et al., 2000), and via
PERK-mediated activation of NF-kB (Jiang et al., 2003). We
found that chyle stimulated IRE1a phosphorylation to promote
XBP1 splicing, and activated PERK, eIF2a, and their down-
stream targets. Activation of ER stress in peritoneal macro-
phages could be reproduced by free palmitic acid but not oleic
or linoleic acid, suggesting the response is mediated by satu-
rated fatty acids.
The mechanism by which saturated fatty acids induce ER
stress has been the subject of recent investigations. Palmitate
but not palmitoleate induced ER stress in pancreatic b cells
(Diakogiannaki et al., 2008). In liver cells saturated fatty acids
induced ER stress independently of ceramide synthesis (Wei
et al., 2006). Stimulation of ER stress by palmitate may occur
via increasing the saturated lipid content of ER membrane phos-
pholipids and TG, leading to compromised ER morphology and
integrity and impaired function of protein-folding chaperones
(Borradaile et al., 2006). Data also point to an important role for
aP2 (Fabp4) in linking saturated fatty acids to ER stress inmacro-
phages via alterations in lipid composition (Erbay et al., 2009).
Several studies have attributed the proinflammatory effect of
saturated fatty acids to activation of TLR4 (Lee et al., 2001; Shi(H) Size of MLN in WT and Angptl4/ mice fed LFD or different types of HFD for 5 weeks. n = 6–7 mice per
HF-lard were significantly different from the other groups as determined by one-way ANOVA followed by Tu
(I) Close correlation between saturated fat content of the diet and the mean plasma level of SAA in Angptl4
(J) Expression of inflammatory marker genes in MLN of WT and Angptl4/ mice fed HFD for 24 hr (study 4
Cell Metabolism 12, 580–592,et al., 2006; Suganami et al., 2007).
Recently, interplay between TLR4 (and
TLR2) and the ER stress pathway was
demonstrated (Woo et al., 2009). IRE1a
was shown to be a positive regulator of
the inflammatory response to TLR activa-
tion in macrophages, while the PERKpathway was not induced by TLR signaling (Martinon et al.,
2010). These data hint at a possible role for TLR signaling in
the response to chyle in macrophages. However, unlike TLR
signaling, chyle dramatically induced ER stress, as evidenced
by the activation of ER stress sensors IRE1a and PERK as well
as their downstream targets. Additionally, whole-genome anal-
ysis of gene regulation by chyle versus LPS revealed some over-
lap, but chyle clearly did not mimic LPS, as illustrated by the
differential response of classic LPS/TLR4-target IL-1b. Although
these data do not rule out a role for TLR signaling inmediating the
inflammatory effects of chyle, induction of ER stress seems
a much more plausible mechanism.
A previous report briefly alluded to development of chylous
ascites in Angptl4/ mice after 20 weeks of HFD (Desai et al.,
2007). In that study it was found that repeated injections of WT
mice fed HFD with a monoclonal antibody against Angptl4 reca-
pitulated the phenotype ofAngptl4/mice. Since the antibody is
directed against the N-terminal portion of Angptl4 and abolishes
its ability to inhibit LPL, the data support the notion that the clin-
ical abnormalities in Angptl4/ mice fed HFD are related to
altered LPL activity, and are independent of C-terminal Angptl4.
Chylous ascites has been observed in mice heterozygous for
the transcription factor Prox1 as well as in mice lacking Angio-
poietin-2. Both proteins are essential for development of the
lymphatic vasculature (Gale et al., 2002; Harvey et al., 2005).
Accordingly, it is tempting to hypothesize a similar role for
Angptl4. However, Prox1+/ and Angiopoietin2/mice develop
chylous ascites shortly after birth, reflecting a severe develop-
mental defect. In contrast, Angptl4/ mice do not exhibit
ascites unless challengedwith HFD for at least 12weeks. Rather,
the data indicate that ascites was secondary to progressive
inflammation originating in MLN macrophages, leading to
massive lymphadenitis and consequent obstruction in mesen-
teric lymph flow, which in turn caused dilation of intestinalgroup. Means of Angptl4/ mice fed HF-palm or
key’s post-hoc test.
/ mice after 3 weeks of feeding.
). n = 3 per group. Error bars represent SEM.
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Figure 6. Angptl4 Inhibits Macrophage Foam Cell Formation and Inflammatory Gene Expression
(A) Heatmap showing changes in expression of selected genes inAngptl4/mouse peritoneal macrophages incubated for 6 hr with chyle (final TG concentration
2 mM) and/or orlistat (20 mM), or with chyle and/or recombinant Angptl4 (2.5 mg/mL). Expression in untreated macrophages was set at 1. In parallel, expression
changes are shown of same genes in peritoneal macrophages treated for 4 hr with LPS (100 ng/mL). All genes induced by chyle by at least 2.5-fold and which are
labeled with ‘‘cytokine or chemokine activity’’ or ‘‘immune or inflammatory response’’ by Gene Ontology (Biological Process) or are involved in immunity/inflam-
mation based on literature study were included. Also, SREBP target genes that were >75% suppressed by chyle were included.
(B) Oil redO staining ofAngptl4/mouse peritoneal macrophages incubated for 6 hr with chyle (TG concentration 2mM) and increasing concentrations ofmouse
recombinant Angptl4. Chyle was collected from rats fed palm oil-based HFD. (Inset) High-magnification image of macrophage foam cell.
(C) Q-PCR expression of inflammatory genes in Angptl4/macrophages treated with chyle and/or Angptl4 (2.5 mg/mL). Asterisk indicates significantly different
according to Student’s t test (p < 0.05).
(D) Q-PCR expression of inflammatory genes inAngptl4/macrophages treated with chyle and various pharmacologic inhibitors. SSO, sulfosuccinimidyl oleate.
Differences were evaluated for statistical significance by one-way ANOVA followed by Tukey’s post-hoc test. Asterisk indicates significantly different from
control-treated cells (p < 0.05). Error bars represent SEM.
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Angptl4 Blocks Saturated Fat-Induced Inflammationlymphatic vessels. Furthermore, inflammation of MLN and
mesenteric fat led to increased local lymphatic and vascular
permeability, as shown by chylous ascites and low SAAG,
respectively, which is indicative of exudative ascites. The more
than 2-fold higher protein concentration in ascites fluid
compared to chyle supports an important contribution of
vascular leakage next to leakage from chyle. Increased circula-
tory leakage caused fibrinogen extravasation, which after clot-
ting accumulated as fibrin and covered abdominal organs.
Chronic inflammation likely gave rise to impaired intestinal
barriers function and translocation of enteric bacteria, causing
peritonitis and death of the animals.
In conclusion, Angptl4 protects against the severe proinflam-
matory effects of dietary saturated fat in MLN by inhibiting
macrophage LPL, thereby reducing lipolytic release of fatty
acids, macrophage foam cell formation, ER stress, and initiation
of a marked inflammatory response. The data illustrate how the
unique anatomy of the intestinal lymphatic system in which
immune cells residing in MLN are exposed to excessive post-
prandial TG concentrations requires activation of an effective
cellular mechanism that protects against elevated lipid uptake
and its complications. It can be speculated that the inability to
effectively recruit this mechanism may contribute to proinflam-
matory changes related to elevated saturated fat consumption.
EXPERIMENTAL PROCEDURES
Animals
Animal studies were done using pure-bredWT and Angptl4/mice on C57Bl/
6 background (Koster et al., 2005). In study 1, male 11-week-oldmice were fed
LFD or HFD for 8 or 19 weeks, providing 10% or 45% energy percent as TG
(D12450B or D12451, Research Diets, Inc., Table S1) (Research Diets
Services, Wijk bij Duurstede, Netherlands), after 3 week run in (adaptation
period) with LFD. In study 2, male 10- to 18-week-old mice were fed LFD or
HFD for 5 weeks, after 2 week run in with LFD. Fat source of the HFDwas either
palm oil (standard HFD used in studies 1, 3, and 4, Table S1), lard, MCT oil, or
safflower oil (Table S2). Blood was collected from tail vein at weekly intervals.
In study 3, male 12-week-old mice were fed standard HFD for 5 weeks, after
2 week run in with standardized LFD AIN93G (see http://testdiet.
purina-mills.com/PDF/57W5.pdf and Table S2). The following antibiotics
were provided in drinkingwater: ampicillin (1 g/L), neomycin (1 g/L), andmetro-
nidazole (0.5 g/L). Blood was collected from tail vein at weekly intervals. In
study 4, mice were fed low-fat AIN93G or standard HFD for 24 hr, after
1 week run in with AIN93G. In the latter studies, low-fat AIN93G was chosen
instead of D12450B to achieve minimal dietary saturated fat intake. Diet
composition is provided in Tables S1 and S2. At the end of each study, mice
were anaesthetized with mixture of isoflurane (1.5%), nitrous oxide (70%),
and oxygen (30%). Blood was collected by orbital puncture into EDTA tubes.
Mice were killed by cervical dislocation, after which tissues were excised and
directly frozen in liquid nitrogen or prepared for histology.
Wistar rats were fed palm oil-based HFD (D12451) overnight. The next
morning, animals were anesthetized using isoflurane, and mesenteric lymph
ducts were cannulated. Chyle was collected for 1–2 hr and stored at 20C.
Chyle TG concentrations averaged at 35 ± 11mMas determined by enzymatic
assay (Instruchemie, Delfzijl, Netherlands). Animal studies were approved by
the local animal ethics committee at Wageningen University.
Two terminally ill animals were transferred to the Small Animal Pathology
laboratory of the Faculty of Veterinary Medicine at Utrecht University for formal
autopsy by a licensed animal pathologist.
Cell Culture
U937 human monocytes were differentiated into macrophages by 24 hr treat-
ment with phorbol myristate acetate (10 ng/mL). U937 macrophages were
subsequently incubated for 6 hr with fatty acids (C16:0, C18:1, C18:2) coupledCell Mto fatty acid free BSA to a final concentration of 500 mM as previously
described (de Vogel-van den Bosch et al., 2008).
To obtain peritoneal macrophages, WT and Angptl4/ mice were injected
intraperitoneally with 1 ml 4% thioglycollate. Three days later, animals were
anesthesized with isoflurane, bled via orbital puncture, and peritoneal cavities
washed using 10 ml ice-cold RPMI medium supplemented with 100 U/mL
penicillin and 100 mg/mL streptomycin (Lonza, Verviers, Belgium). Cell pellets
were incubated with RBC lysis buffer on ice for 5 min and subsequently
washed with RPMI medium supplemented with 10% fetal bovine serum
(FBS) (Lonza) and antibiotics, repelletized, and seeded at density of 3 3 105
cells/cm2. Two hours later, cells were washed twice with PBS to remove non-
adherent cells and provided with medium. Two days later, cells were exposed
to chyle at TG concentration of 2 mM for 6 hr preceded by preincubation
with 20 mM orlistat (Sigma Zwijndrecht, Netherlands) or 2.5 mg/mL mouse
recombinant Angptl4 (R&D Systems, Abingdon, UK) for 1.5 hr. To explore
the mechanism induced by chyle, Angptl4/ macrophages were preincu-
batedwith 10 mMmyriocin, 10 mg/ml Polymyxin B, or 0.5mMSulfosuccinimidyl
oleate (SSO) for 30 min followed by exposure of cells to either PBS or chyle at
TG concentration of 2 mM for 6 hr. In ER stress experiments, Angptl4/
macrophages were exposed to 100 nM thapsigargin, 2.5 mg/ml tunicamycin,
or chyle (TG 2 mM) for 6 hr. Analysis of ER stress in peritoneal macrophages
was carried out as described (Yang et al., 2010).
Histology/Immunohistochemistry
Hematoxylin and eosin (H&E) staining of sections was performed using stan-
dard protocols. For detection of macrophages, immunohistochemistry was
performed using antibody against Cd68 (liver, adipose tissue) or F4/80 (lymph
nodes) (Serotec, Oxford, UK). Paraffin-embedded sections were preincubated
with 20% normal goat serum followed by overnight incubation at 4C with
primary antibody diluted 1:50 in PBS/1% BSA. After incubation with primary
antibody, goat anti-rat IgG conjugated to horseradish peroxidase (Serotec)
was used as secondary antibody. Visualization was performed using AEC
Substrate Chromogen (Cd68) or 3,30-diaminobenzidine (F4/80). Negative
controls were prepared by omitting primary antibody.
For Sirius red staining, paraffin-embedded sections of small intestine were
mounted on Superfrost microscope slides. Sections were dewaxed in xylene
and rehydrated in series of graded alcohols. Slides were stained in picrosirius
red 0.1% picric acid for 90 min and rinsed in acidified H2O 0.5% acetic acid.
Oil red O stock solution was prepared by dissolving 0.5 g oil red O (Sigma,
#O0625) in 500 ml isopropanol. Oil red O working solution was prepared by
mixing 30 ml oil red O stock with 20 ml dH2O, followed by filtration. Sections
(5 mm) were cut from frozen MLNs embedded in OCT. Sections were air dried
for 30 min, rehydrated in dH2O, and fixated for 10 min in formal calcium (4%
formaldehyde, 1% CaCl2). Sections were immersed in oil red O working solu-
tion for 10 min, followed by two rinses with dH2O. Hematoxylin nuclei staining
was subsequently carried out for 5 min followed by several rinses with dH2O.
Sections were mounted in aqueous mountant (Imsol, Preston, UK).
For Sudan black staining, 0.5 g Sudan black (Sigma, #86015) was dissolved
in 100 ml warm 70% ethanol and subsequently filtered. Sections were fixed
and rehydrated as above. After two 3 min rinses with 50% ethanol and two
quick rinses with dH2O, sections were immersed in Sudan black solution for
10 min, followed by two rinses with dH2O. Sections were mounted in aqueous
mountant (Imsol, Preston, UK).
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Figure 7. Angptl4 Prevents Chyle-Induced ER Stress
(A) Immunoblots of IRE1a, PERK, eIF2a, and CHOP using regular gels or Phos-tag gels (IRE1a only) of Angptl4/macrophages treated with chyle (TG concen-
tration 2 mM), thapsigargin (100 nM), or tunicamycin (2.5 mg/mL) for 6 hr. ‘‘P’’ represents phosphorylated form.
(B) Regular RT-PCR of XBP1 processing revealing spliced and unspliced XBP1 mRNA.
(C) Q-PCR expression of ER stress genes. Differences were evaluated for statistical significance by one-way ANOVA followed by Tukey’s post-hoc test. Asterisk
indicates significantly different from control-treated cells (p < 0.05).
(D) Q-PCR expression of selected genes involved in ER stress in Angptl4/ mouse peritoneal macrophages incubated for 6 hr with chyle and/or recombinant
Angptl4 (2.5 mg/mL). Asterisk indicates significantly different according to Student’s t test (p < 0.05).
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